e-learning
resources
Virtual 2021
06.09.2021
Screening, diagnosis, management and prognosis of lung cancer
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Proportion of incident lung cancers that would have been eligible for a lung cancer screening program in Australia
M. Turner (Canberra, Australia), L. Smyth (Canberra, Australia), N. Taylor (Canberra, Australia), S. Schembri (Canberra, Australia)
Source:
Virtual Congress 2021 – Screening, diagnosis, management and prognosis of lung cancer
Session:
Screening, diagnosis, management and prognosis of lung cancer
Session type:
E-poster
Number:
2177
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Turner (Canberra, Australia), L. Smyth (Canberra, Australia), N. Taylor (Canberra, Australia), S. Schembri (Canberra, Australia). Proportion of incident lung cancers that would have been eligible for a lung cancer screening program in Australia. 2177
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
Related content which might interest you:
The proportion of lung cancer patients attending UK lung cancer clinics who would have been eligible for low-dose CT screening
Source: Eur Respir J, 54 (2) 1802221; 10.1183/13993003.02221-2018
Year: 2019
Lung nodules in a lung cancer screening program: incidence density of lung cancer in patients with COPD and/or emphysema
Source: Annual Congress 2009 - Epidemiology and management of lung cancer
Year: 2009
The efficacy of COPD detection by using a community-based annual screening program for lung cancer
Source: Annual Congress 2012 - Methodology in epidemiologic research
Year: 2012
Other cancers in lung cancer families are overwhelmingly smoking-related cancers
Source: ERJ Open Res, 3 (2) 00006-2017; 10.1183/23120541.00006-2017
Year: 2017
Resectable proportion of lung cancers in an unselected population
Source: Annual Congress 2008 - Management, quality aspects and prognosis in thoracic oncology
Year: 2008
The evaluation of lung cancer patients
Source: Eur Respir J 2005; 26: Suppl. 49, 323s
Year: 2005
Screening for lung cancer
Source: International Congress 2017 – Lung cancer for the pulmonologist
Year: 2017
Prior lung disease and risk of lung cancer in women
Source: Eur Respir J 2005; 26: Suppl. 49, 598s
Year: 2005
Lung cancer screening in COPD patients.
Source: International Congress 2018 – Interdependence of COPD and comorbidities and the underlying mechanisms
Year: 2018
Prevalence and burden of bronchiectasis in a lung cancer screening program
Source: International Congress 2019 – Airway infection in COPD
Year: 2019
Factors determining early adherence to a lung cancer screening protocol
Source: Eur Respir J 2007; 30: 532-537
Year: 2007
Minimally-invasive investigation for lung cancer in a high-risk cohort
Source: Annual Congress 2013 –Early detection of lung cancer
Year: 2013
Management of lung cancer screening and incidental findings as well as their integration in existing lung cancer care
Source: International Congress 2019 – PG1 Lung cancer: the key multidisciplinary approach
Year: 2019
Surgically treated lung cancer patients: do they all smoke and would they all have been detected with lung cancer screening?
Source: ERJ Open Res, 4 (3) 00001-2018; 10.1183/23120541.00001-2018
Year: 2018
The cost of lung cancer in Turkey
Source: Eur Respir J 2004; 24: Suppl. 48, 303s
Year: 2004
Interstital lung disease rates and risk factors in a UK lung cancer screening trial
Source: International Congress 2018 – The world of idiopathic pulmonary fibrosis (IPF): global registries
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept